Prognostic significance of platelet-lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer.

Tae Ju ParkYang Hyun ChoHo Seok ChungEu Chang HwangSung-Hoon JungJun Eul HwangWoo Kyun BaeJin Woong KimSuk Hee HeoYoung Hoe HurSeung Il JungDong Deuk Kwon

Published in: SpringerPlus (2016)

High PLR was associated with shorter survival of mRCC patients receiving first-line TKI. The PLR may be an effective independent prognostic factor in this setting.

Keyphrases

prognostic factors
papillary thyroid
chronic myeloid leukemia
single cell
squamous cell carcinoma
small cell lung cancer
squamous cell
tyrosine kinase
cell therapy
peripheral blood
stem cells
childhood cancer
young adults
epidermal growth factor receptor
mesenchymal stem cells